RIGL Dividend: Rigel Pharmaceuticals Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	282	179	116	120	149	108
Revenue Growth (YoY)	80%	54%	-3%	-19%	38%	83%
Cost of Revenue	19	18	7	1	1	0
Gross Profit	262	160	109	118	148	107
Selling, General & Admin	115	113	105	112	91	76
Research & Development	28	23	24	60	65	60
Operating Expenses	143	136	130	172	157	136
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	114	18	-25	-58	-17	-29
Income Tax Expense	1	0	--	0	0	--
Net Income	113	17	-25	-58	-17	-29
Net Income Growth	3,667%	-168%	-56.99%	241%	-41%	-56%
Shares Outstanding (Diluted)	19.15	17.68	17.4	172.4	170.5	168.8
Shares Change (YoY)	9%	2%	-90%	1%	1%	1%
EPS (Diluted)	5.91	0.98	-1.44	-0.34	-0.11	-0.18
EPS Growth	2,627%	-169%	324%	209%	-39%	-55%
Free Cash Flow	68	31	-20	-74	5	-53
Free Cash Flow Per Share	3.54	1.75	-1.14	-0.42	0.02	-0.31
Gross Margin	92.9%	89.38%	93.96%	98.33%	99.32%	99.07%
Operating Margin	41.84%	13.4%	-17.24%	-45%	-6.04%	-26.85%
Profit Margin	40.07%	9.49%	-21.55%	-48.33%	-11.4%	-26.85%
Free Cash Flow Margin	24.11%	17.31%	-17.24%	-61.66%	3.35%	-49.07%
EBITDA	120	26	-19	-53	-8	-29
EBITDA Margin	42.55%	14.52%	-16.37%	-44.16%	-5.36%	-26.85%
D&A For EBITDA	2	2	1	1	1	0
EBIT	118	24	-20	-54	-9	-29
EBIT Margin	41.84%	13.4%	-17.24%	-45%	-6.04%	-26.85%
Effective Tax Rate	0.87%	0%	--	0%	0%	--

Rigel Pharmaceuticals Inc (RIGL) Price